title: Effect of imatinib mesylate (Gleevec) on anaplastic thyroid carcinoma cell lines.
authors.forename: Constantine S
authors.initials: CS
authors.lastname: Mitsiades
authors.forename: Despoina
authors.initials: D
authors.lastname: Sykoutri
authors.forename: Ciaran
authors.initials: C
authors.lastname: McMullan
authors.forename: Vassiliki
authors.initials: V
authors.lastname: Poulaki
authors.forename: Nicholas
authors.initials: N
authors.lastname: Mitsiades
mesh_terms: D000970:Antineoplastic Agents / Q000494:pharmacology*; D001549:Benzamides; D002277:Carcinoma; D006801:Humans; D000068877:Imatinib Mesylate; D010879:Piperazines / Q000494:pharmacology*; D011743:Pyrimidines / Q000494:pharmacology*; D013964:Thyroid Neoplasms; D014407:Tumor Cells, Cultured / Q000187:drug effects
chemical_list: D000970:Antineoplastic Agents; D001549:Benzamides; D010879:Piperazines; D011743:Pyrimidines; D000068877:Imatinib Mesylate